Release Date: 26/10/09 09:09 Summary: Acquisition and Capital Raising Price Sensitive: Yes Download Document 95.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%